Building a best-in-class de-identification tool for electronic medical records through ensemble learning

(May 12, 2021)

Originally Posted in medRxiv

(Feb. 23, 2021)

Karthik Murugadoss, Ajit Rajasekharan, Bradley Malin, Vineet...

more

Authored by nference  Mayo Clinic  Vanderbilt University Medical Center

The natural language portions of an electronic health record (EHR) communicate critical information about disease and treatment progression. However, the presence of personally identifying information in this data constrains its broad reuse. In the United States, the Health Insurance Portability ...
Correspondence: Venky Soundararajan (venky@nference.net), Sankar Ardhanari (sankar@nference.net)


Real-world effectiveness of Ad26.COV2.S adenoviral vector vaccine for COVID-19

Posted in medRxiv

(Apr. 30, 2021)

Juan Corchado-Garcia, David Puyraimond-Zemmour, Travis Hughes ,...

more

Authored by nference Mayo Clinic

In light of the massive and rapid vaccination campaign against COVID-19, continuous real-world effectiveness and safety assessment of the FDA-authorized vaccines is critical to amplify transparency, build public trust, and ultimately improve ...
 
Correspondence: Venky Soundararajan (venky@nference.net),  Tyler Wagner (tyler@nference.net)
 


Pre-existing conditions are associated with COVID-19 patients' hospitalization, despite confirmed clearance of SARS-CoV-2 virus

(Mar. 23, 2021)

Originally Posted in medRxiv

(Nov. 3, 2020)

Colin PawlowskiAJ VenkatakrishnanEshwan RamuduChristian Kirkup...

more

Authored by nference  Mayo Clinic

The current diagnostic gold-standard for SARS-CoV-2 clearance from infected patients is two consecutive negative PCR test results. However, there are anecdotal reports of hospitalization from protracted COVID ...

Correspondence: Venky Soundararajan (venky@nference.net)



FDA-authorized COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system

Posted in medRxiv

(Feb. 27, 2021)

Originally Posted in OSF Preprints

(Feb. 17, 2021)

Featured in Bloomberg

Colin Pawlowski, Patrick Lenehan, Arjun Puranik, Vineet Agarwal, AJ...

more

Authored by nference  Mayo Clinic

Large Phase 3 clinical trials of the two FDA-authorized COVID-19 vaccines, mRNA-1273 (Moderna) and BNT162b2 (Pfizer/BioNTech), have demonstrated efficacies of 94.1% (n = 30,420, 95% CI: 89.3-96.8) and 95% (n = 43,448, 95% CI: 90.3-97.6) in preventing symptomatic COVID-19, respectively ...

Correspondence:  Venky Soundararajan (venky@nference.net)

FDA


Real-time analysis of a mass vaccination effort via an Artificial Intelligence platform confirms the safety of FDA-authorized COVID-19 vaccines

Posted in medRxiv

(Feb. 27, 2021)

Reid McMurry, Patrick J Lenehan, Samir Awasthi, Eli Silvert, Arjun...

more
more

Authored by nference  Mayo Clinic

As the COVID-19 vaccination campaign unfolds as one of the most rapid and widespread in history, it is important to continuously assess the real world safety of the FDA-authorized vaccines. Curation from large-scale electronic health records (EHRs) allows for near real-time safety evaluations that were not previously possible ...

Correspondence: Venky Soundararajan (venky@nference.net)